CRX.L Regulatory News (CRX)

20 Apr 2005 07:00

Cyprotex PLC20 April 2005 Press release 20 April 2005 Cyprotex PLC Issue of 130,710 shares pursuant exercise of options Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that it has issued 130,710 new Ordinary Shares of0.1 p each ("new Ordinary Shares") pursuant to the exercise of options. The issue of the new Ordinary Shares is subject to the new Ordinary Shares beingadmitted to trading on AIM, application for which will be made. Trading in thenew Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 25th April, 2005. For further information:Cyprotex PLCRobert Morrisson Atwater Tel: 01625 505100 Code Securities LimitedCharles Walker Tel: 020 7024 2000 Media enquiries:AbchurchHenry Harrison-Topham / Heather Salmond Tel: 020 7398 7700 This information is provided by RNS The company news service from the London Stock Exchange